SummARy

pheni date, modafinil) reduce fatigue, promote alertness and wakefulness, and have possible moodenhancing properties. In modern psychiatric practice, their use has been limited to attention deficit hyperactivity disorder and sleep disorders such as narcolepsy. Despite this, research has continued into psychostimulant use in general psychiatry, especially in the treatment of depression and fatigue. This article reviews the recent literature regarding psychostimulant use in general and consultationliaison psychiatry. Although psychostimulants continue to attract clinical research, there is currently not enough evidence to recommend their routine use for general psychiatric conditions